Vaccination against infections in chronic lymphocytic leukemia
- PMID: 12769342
- DOI: 10.1080/1042819031000063408
Vaccination against infections in chronic lymphocytic leukemia
Abstract
Chronic lymphocytic leukemia (CLL) is a well-defined mature B-cell neoplasm associated with increased susceptibility to infections. Two major options in prevention of infections in CLL, intravenous gammaglobulin treatment and antimicrobial chemoprophylaxis, have not resulted in satisfactory outcome. A third strategy, antimicrobial vaccination, is the topic of this minireview. We collected articles and their references concerning CLL vaccination from the Medline database starting from 1966 and thirteen relevant studies were found. Plain bacterial polysaccharide vaccines would seem to be ineffective in antibody formation in patients with CLL. However, protein and conjugate vaccines appear to be more immunogenic and their responses may be further enhanced with ranitidine adjuvant treatment. New well-designed investigations are needed to develop appropriate vaccination strategies and evaluate vaccination efficacy in infection morbidity and mortality in CLL.
Similar articles
-
Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.Vaccine. 2018 Jun 14;36(25):3701-3707. doi: 10.1016/j.vaccine.2018.05.012. Epub 2018 May 7. Vaccine. 2018. PMID: 29748028
-
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia.Leukemia. 1995 Nov;9(11):1902-9. Leukemia. 1995. PMID: 7475282 Clinical Trial.
-
Room for improvement: immunizations for patients with monoclonal B-cell lymphocytosis or chronic lymphocytic leukemia.Clin Adv Hematol Oncol. 2014 Jul;12(7):440-50. Clin Adv Hematol Oncol. 2014. PMID: 25322324 Review.
-
Vaccination efficacy in patients with chronic lymphocytic leukemia.Leuk Lymphoma. 2023 Jan;64(1):42-56. doi: 10.1080/10428194.2022.2133538. Epub 2022 Oct 21. Leuk Lymphoma. 2023. PMID: 36270021 Review.
-
Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for response.Leuk Lymphoma. 2002 Oct;43(10):1967-9. doi: 10.1080/1042819021000015916. Leuk Lymphoma. 2002. PMID: 12481893 Clinical Trial.
Cited by
-
A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency.Infect Dis Ther. 2021 Jun;10(2):637-661. doi: 10.1007/s40121-021-00404-y. Epub 2021 Mar 9. Infect Dis Ther. 2021. PMID: 33687662 Free PMC article. Review.
-
A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia.Curr Oncol. 2016 Feb;23(1):42-51. doi: 10.3747/co.23.2810. Epub 2016 Feb 18. Curr Oncol. 2016. PMID: 26966403 Free PMC article. Review.
-
Chronic lymphocytic leukemia: biology and current treatment.Curr Oncol Rep. 2007 Sep;9(5):345-52. doi: 10.1007/s11912-007-0046-8. Curr Oncol Rep. 2007. PMID: 17706162 Review.
-
Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.Mediterr J Hematol Infect Dis. 2013 Nov 4;5(1):e2013068. doi: 10.4084/MJHID.2013.068. Mediterr J Hematol Infect Dis. 2013. PMID: 24363883 Free PMC article. Review.
-
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.Blood. 2021 Nov 4;138(18):1768-1773. doi: 10.1182/blood.2021011841. Blood. 2021. PMID: 34297826 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical